Review

Published on 21 Apr 2023

Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Dan Peng
Yongqing Cai
Geng Chen
Min Hou
Xiaofeng Luo
Zhuoma Dongzhi
Hongjun Xie
Yao Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1101063

3,744 views
7 citations

Systematic Review

Published on 21 Apr 2023

Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers

in Pharmacology of Anti-Cancer Drugs

Shun-Long Ou
Jing Luo
Hua Wei
Xiao-Li Qin
Qian Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1106961

2,948 views

Review

Published on 21 Apr 2023

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future

in Pharmacology of Anti-Cancer Drugs

Brigida Anna Maiorano
Mauro Francesco Pio Maiorano
Evaristo Maiello

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162665

6,016 views
10 citations

Review

Published on 21 Apr 2023

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review

in Pharmacology of Anti-Cancer Drugs

Jiaqi Zhai
Xi Gu
Yang Liu
Yueting Hu
Yi Jiang
Zhenyong Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1152934

7,347 views
39 citations

Review

Published on 20 Apr 2023

Lenvatinib resistance mechanism and potential ways to conquer

in Pharmacology of Anti-Cancer Drugs

Wentao Bo
Yan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1153991

5,910 views
8 citations

Review

Published on 20 Apr 2023

Role of voltage-gated proton channel (Hv1) in cancer biology

in Pharmacology of Anti-Cancer Drugs

Juan J. Alvear-Arias
Antonio Pena-Pichicoi
Christian Carrillo
Miguel Fernandez
Tania Gonzalez
Jose A. Garate
Carlos Gonzalez

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1175702

3,235 views
2 citations

Review

Published on 20 Apr 2023

The role of NLRP3 inflammasome in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Huijie Zhao
Yiming Zhang
Yanting Zhang
Chaoran Chen
Huiyang Liu
Yihan Yang
Honggang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1150325

3,523 views
5 citations

Systematic Review

Published on 20 Apr 2023

Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Tengteng Jian
Yang Zhan
Ying Yu
Kai Yu
Rui Hu
Jixue Wang
Ji Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1148021

6,357 views
6 citations

Original Research

Published on 19 Apr 2023

Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study

in Pharmacology of Anti-Cancer Drugs

Yu Min
Xiaoyuan Wei
Zheran Liu
Zhigong Wei
Yiyan Pei
Ruidan Li
Jing Jin
Yongllin Su
Xiaolin Hu
Xingchen Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1109580

5,598 views
4 citations

Editorial

Published on 19 Apr 2023

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022

in Pharmacology of Anti-Cancer Drugs

Husain Yar Khan
Khuloud Bajbouj
Mai F. Tolba

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191321

1,553 views

Original Research

Published on 19 Apr 2023

Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids

in Pharmacology of Anti-Cancer Drugs

Amira Abugomaa
Mohamed Elbadawy
Yusuke Ishihara
Haru Yamamoto
Masahiro Kaneda
Hideyuki Yamawaki
Yuta Shinohara
Tatsuya Usui
Kazuaki Sasaki

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1159516

22,468 views
9 citations

Review

Published on 19 Apr 2023

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges

in Pharmacology of Anti-Cancer Drugs

Ying Chen
Jishi Wang
Fengqi Zhang
Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1151032

7,632 views
6 citations

Original Research

Published on 17 Apr 2023

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma

in Pharmacology of Anti-Cancer Drugs

Yuming Sun
Shaorong Lei
Xiangyue Luo
Chufeng Jiang
Zhexuan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1129544

2,302 views
3 citations

Original Research

Published on 17 Apr 2023

Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer

in Pharmacology of Anti-Cancer Drugs

Shengmin Zhang
Jianrong Yang
Hongsheng Wu
Tiansheng Cao
Tengfei Ji

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1091378

2,275 views
3 citations

Original Research

Published on 17 Apr 2023

Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer

in Pharmacology of Anti-Cancer Drugs

Chen Feng
Rongzhang Chen
Weiwei Fang
Xinran Gao
Hanjie Ying
Xiao Zheng
Lujun Chen
Jingting Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1144330

2,931 views
7 citations

Review

Published on 17 Apr 2023

An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer

in Pharmacology of Anti-Cancer Drugs

Jovana Rajkovic
Radmila Novakovic
Jelica Grujic-Milanovic
Alibek Ydyrys
Nurzhanat Ablaikhanova
Daniela Calina
Javad Sharifi-Rad
Basem Al-Omari

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1160616

4,085 views
10 citations

Navigation group

Articles

Efficacy and safety of apatinib versus sorafenib/placebo in first-line treatment for intermediate and advanced primary liver cancer: A systematic review and meta-analysis

Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers

Olaparib and advanced ovarian cancer: Summary of the past and looking into the future

Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: An update review

Lenvatinib resistance mechanism and potential ways to conquer

Role of voltage-gated proton channel (Hv1) in cancer biology

The role of NLRP3 inflammasome in hepatocellular carcinoma

Combination therapy for high-volume versus low-volume metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis

Assessing the role of lipid-lowering therapy on multi-cancer prevention: A mendelian randomization study

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022

Anti-cancer activity of Chaga mushroom (Inonotus obliquus) against dog bladder cancer organoids

A perspective of immunotherapy for acute myeloid leukemia: Current advances and challenges

The value of cuproptosis-related differential genes in guiding prognosis and immune status in patients with skin cutaneous melanoma

Establishment of a 7-gene prognostic signature based on oxidative stress genes for predicting chemotherapy resistance in pancreatic cancer

Synergistic effect of CD47 blockade in combination with cordycepin treatment against cancer

An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer